CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −9,003 | $159.78 | $1.4M | 158,518 |
| 2025-10-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −3,976 | $160.49 | $638K | 154,542 |
| 2025-10-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −470 | $161.47 | $76K | 154,072 |
| 2025-09-30 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,364 | $162.05 | $221K | 203,300 |
| 2025-09-30 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −9,109 | $162.05 | $1.5M | 168,155 |
| 2025-09-30 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,491 | $162.05 | $404K | 69,189 |
| 2025-09-29 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +2,500 | 204,664 | ||
| 2025-09-29 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −2,500 | 0 | ||
| 2025-09-29 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise 10b5-1 | +18,750 | 177,264 | ||
| 2025-09-29 | Chapman Steven Leonard CEO AND PRESIDENT | Option exercise · Restricted Stock Unit 10b5-1 | −18,750 | 0 | ||
| 2025-09-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +6,250 | 71,680 | ||
| 2025-09-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −6,250 | 0 | ||
| 2025-09-19 | Sheena Jonathan Director | Sale 10b5-1 | −3,444 | $179.08 | $617K | 30,838 |
| 2025-09-19 | Sheena Jonathan Director | Sale 10b5-1 | −1,380 | $179.88 | $248K | 29,458 |
| 2025-09-19 | Sheena Jonathan Director | Sale 10b5-1 | −676 | $180.68 | $122K | 28,782 |
| 2025-09-19 | Sheena Jonathan Director | Sale 10b5-1 | −3,602 | $179.09 | $645K | 30,680 |
| 2025-09-19 | Sheena Jonathan Director | Sale 10b5-1 | −1,518 | $180.06 | $273K | 29,162 |
| 2025-09-19 | Sheena Jonathan Director | Sale 10b5-1 | −380 | $180.68 | $69K | 28,782 |
| 2025-09-19 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −24,339 | $180.54 | $4.4M | 2,322,040 |
| 2025-09-19 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −1,188 | $181.28 | $215K | 2,320,852 |
Page 38 of 39 · 767 trades